Clinical trials
Completed Carcinoma in Situ trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Protara Therapeutics | 2 |
| Anandasabapathy, Sharmila, M.D. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| CG Oncology, Inc. | 1 |
| Children's Oncology Group | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma in Situ | 17 |
| Urinary Bladder Neoplasms | 6 |
| Non-Muscle Invasive Bladder Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Head and Neck Neoplasms | 2 |
| Hyperplasia | 2 |
| Barrett Esophagus | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.